Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Velocity Clinical Research - Ahrensburg, Germany

Verified

Basic Information

Site Overview

Source: Human-provided.

Velocity Clinical Research Germany GmbH – Ahrensburg is a dedicated clinical trial research site located in Ahrensburg, Germany. The facility is part of the global Velocity Clinical Research network, an integrated site organization that partners with pharmaceutical and biotechnology companies to support the development of new drugs, medical devices, and diagnostic technologies. The Ahrensburg site was originally founded in 1999 as the Pulmonary Research Institute at the LungenClinic Grosshansdorf and later became part of Velocity Clinical Research, strengthening the company’s clinical research capabilities in Europe. The center conducts clinical trials across multiple therapeutic areas, with particular expertise in pulmonary and respiratory diseases. The site collaborates closely with local medical specialists and maintains a strong patient database to support efficient recruitment and high-quality clinical research. With experienced investigators and trained research staff, the…

Source: Trial-derived.
4Total Trials
Source: Trial-derived.
1Recruiting Trials
Source: Trial-derived.
2Active Trials
Source: Trial-derived.
2Completed Trials
Source: Trial-derived.
4Unique Conditions
Source: Trial-derived.
1Unique Sponsors

Affiliations

Conditions

Source: Trial-derived. Idiopathic Pulmonary Fibrosis (2)Source: Trial-derived. Bronchiectasis (1)Source: Trial-derived. Lung Diseases, Interstitial (1)Source: Trial-derived. Progressive Pulmonary Fibrosis (1)

Sponsors

Source: Trial-derived. Boehringer Ingelheim (4)

Research Technology

Research technology inferred from trial participation

Source: AI-inferred. Telehealth study visits

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Spirometry
Source: AI-inferred. CT Scan
Source: AI-inferred. Full pulmonary function lab (DLCO / plethysmography)

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Electronic patient-reported outcome collection